Brief: Owens & Minor Launches Financing for Rotech Acquisition, Reports Prelim Q4 Results
Feb 3 (Reuters) - Owens & Minor Inc OMI.N :
* OWENS & MINOR LAUNCHES FINANCING FOR ROTECH ACQUISITION
AND
PROVIDES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL
RESULTS AHEAD OF INVESTOR MEETINGS
* Q4 2024 REVENUE EXPECTED TO BE $2.67-$2.70 BILLION
* Q4 2024 ADJUSTED EPS EXPECTED TO BE $0.52-$0.55
* EXPECTED NON-CASH GOODWILL IMPAIRMENT CHARGE OF $310
MILLION
* Q4 EARNINGS PER SHARE VIEW $0.53, REVENUE VIEW $2.73
BILLION --
LSEG IBES DATA
Source text: ID:nBw4xxl6Wa
Further company coverage: OMI.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Accendra Health
See all newsBrief: Accendra Health Receives Continued Listing Standard Notice From NYSE
Brief: Accendra Health Names Kenneth Gardner-Smith As President And Chief Executive Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Accendra Health Inc reports results for the quarter ended June 30 - Earnings Summary
Accendra Health Q2 profit, revenue miss estimates on large payor exit